September 14, 2026

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Navigating a 10.92% Potential Downside Amidst Healthcare Sector Innovations

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a prominent player in the healthcare sector, specifically within the medical devices industry. Headquartered in Hercules, California, the company has carved out a..

Ionis Pharmaceuticals (IONS) Stock Analysis: Biotechnology Player with 55% Upside Potential and Strong Analyst Confidence

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) operates at the forefront of the biotechnology sector, specializing in RNA-targeted medicines. Despite the challenges reflected in its recent financial performance, the company presents a..

Bruker Corporation (BRKR) Stock Analysis: Evaluating Growth Potential with a 10.86% Upside

Bruker Corporation (NASDAQ: BRKR), a key player in the healthcare sector specializing in medical devices, offers investors an intriguing opportunity with a projected potential upside of 10.86%. Headquartered in Billerica,..

AbbVie Inc. (ABBV) Stock Analysis: A $454 Billion Giant with Upside Potential and Strong Buy Ratings

AbbVie Inc. (NYSE: ABBV), a titan in the healthcare sector, continues to capture investor attention with its robust portfolio and promising growth trajectory. Operating within the drug manufacturers industry, AbbVie..

Medpace Holdings, Inc. (MEDP) Stock Analysis: A Resilient Growth Story with a Strong ROE

Medpace Holdings, Inc. (NASDAQ: MEDP) is carving out a formidable presence in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $16.4 billion, this..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unveiling an 18% Potential Upside in Healthcare Solutions

Stevanato Group S.p.A. (STVN), a prominent player in the healthcare sector, is drawing attention from investors with a significant 18.06% potential upside in its stock price. The company, headquartered in..

Oscar Health, Inc. (OSCR) Stock Analysis: Riding a 70.4% Revenue Growth Wave in the Healthcare Sector

Oscar Health, Inc. (NYSE: OSCR) has made waves in the healthcare sector with its innovative approach to health insurance and technology integration. Operating in the U.S. as a healthcare technology..

Tempus AI, Inc. (TEM): Investor Outlook with a 15.53% Upside Potential

Tempus AI, Inc. (NASDAQ: TEM), a prominent player in the healthcare technology sector, is drawing attention from investors due to its innovative platforms and strategic partnerships. With a market capitalization..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating Market Challenges with a 17.97% ROE

Inspire Medical Systems, Inc. (NASDAQ: INSP) continues to capture the attention of investors within the healthcare sector, particularly those focused on medical devices. With a market capitalization of $2.11 billion,..

Legend Biotech Corporation (LEGN) Stock Analysis: Exploring a 160% Potential Upside with Innovative Therapies

For investors with an eye on the healthcare sector, Legend Biotech Corporation (NASDAQ: LEGN) presents a compelling opportunity, especially considering the staggering 160.08% potential upside based on its current average..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotech Gem with a 29% Upside Potential

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biotechnology sector, has garnered significant attention with its strategic focus on B-cell mediated diseases. With a robust market capitalization of..

Elanco Animal Health (ELAN) Stock Analysis: Exploring a 34.72% Potential Upside

Elanco Animal Health Incorporated (NYSE: ELAN), a key player in the healthcare sector specializing in animal health, presents an intriguing opportunity for investors with its significant potential upside. With a..

AptarGroup, Inc. (ATR) Investor Outlook: Assessing a 36% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $7.94 billion, the company has carved..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 43.91% Potential Upside Amidst a Challenging Market

Grifols, S.A. (NASDAQ: GRFS), a key player in the healthcare sector specializing in the manufacture of plasma-derived medicines, stands at a pivotal point in its market trajectory. With a compelling..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: A Promising 58% Upside for Healthcare Innovators

iRhythm Holdings, Inc. (NASDAQ: IRTC) presents an intriguing opportunity for investors, particularly those interested in the healthcare sector’s innovative edge. This San Francisco-based company specializes in digital healthcare solutions, specifically..

Corcept Therapeutics (CORT) Stock Analysis: Uncovering a 25% Potential Upside in the Biotech Sector

Corcept Therapeutics Incorporated (CORT), a prominent player in the biotechnology industry, is garnering attention for its innovative approach to treating severe endocrinologic, oncologic, metabolic, and neurologic disorders. Given its market..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: An 18% Upside Potential Beckons Investors

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotech industry, is capturing investor attention with a compelling growth trajectory and a robust portfolio of innovative therapeutics. Headquartered in..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A 38% Potential Upside for Investors

IDEXX Laboratories, Inc. (NASDAQ: IDXX) is making waves in the healthcare sector, particularly within the Diagnostics & Research industry. With a formidable market cap of $39.76 billion, IDEXX is a..

Globus Medical, Inc. (GMED) Stock Analysis: Navigating a 39% Potential Upside in the Medical Devices Sector

For investors seeking opportunities in the healthcare sector, particularly within the burgeoning field of medical devices, Globus Medical, Inc. (NYSE: GMED) presents a compelling case. With a market capitalization of..

Boston Scientific Corporation (BSX) Stock Analysis: Exploring a 45% Upside Potential

Boston Scientific Corporation (NYSE: BSX) stands as a formidable player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $62.29 billion, Boston Scientific has..

Search

Funds

September 14, 2026

Search

Funds

September 14, 2026

FTSE 100

Funds